FDA Budget Includes 61% PDUFA Increase; Agency Wants Proposal By May
This article was originally published in The Tan Sheet
Executive Summary
FDA aims to reach an agreement with industry on the framework for reauthorization of the Prescription Drug User Fee Act by May, Acting Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 5 during a press briefing on the FDA budget
You may also be interested in...
PDUFA III Deal Includes Risk Management Fees In “Peri-Approval” Phase
The FDA/industry PDUFA III agreement includes funding to expand FDA's Office of Drug Safety by 100 full-time equivalent staff positions over five years
NCCAM Funding Hike Proposed By Bush Administration
A 6.6% funding boost for the National Center for Complementary & Alternative Medicine falls toward the lower end of requested increases for NIH divisions under the Bush Administration's FY 2003 budget proposal
PDUFA III Or Hatch/Waxman II?: Payors Urge Fix For Generic “Loopholes”
Supporters of the generic industry's Hatch/Waxman agenda are eyeing the Prescription Drug User Fee Act reauthorization as a potential vehicle for reform measures